Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance
Cancer Medicine · 2026-03 · 15 (3)
DOI: 10.1002/cam4.71737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 24.03.2026. Verfasst von Xin Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wu…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Lymphocytes, Tumor-Infiltrating, Carcinoma, Transitional Cell. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immune cells have been linked to the initiation and progression of tumors, and their presence is often used to predict disease prognosis. However, when it comes to bladder urothelial carcinoma (BLCA), there has not been a comprehensive investigation into the function and prognostic value of different immune cell types.
Methods
We integrated data from more than 2300 BLCA patients across 14 public datasets. Then we analyzed the quantity of 170 different immune cell signatures using the ssGSEA algorithm. Through meta‐analysis and univariable Cox analysis, we identified prognosis‐associated immune cells and established an immune cell related prognostic signature (IRPS). We then conducted survival analyses to observe the differences in survival across different IRPS‐risk groups. Furthermore, based on the DEGs associated with IRPS, we screened for potential targeted therapeutic agents. Finally, we integrated IRPS with clinical features to establish a comprehensive prognostic index (ICPI).
Results
Our analysis identified 90 immune cell types that were particularly relevant to BLCA. Then we constructed and validated the IRPS, with high IRPS significantly associated with longer overall survival (HR = 0.73, 95% CI, 0.71–0.76, p < 0.001). In two independent immunotherapy cohorts (IMvigor210 and GSE78220), patients with high IRPS demonstrated significantly prolonged survival following immune checkpoint inhibitor treatment ( p = 0.035, p = 0.019). Several candidate drugs targeting IRPS were identified. The ICPI, developed by integrating IRPS with clinical features, also demonstrated enhanced accuracy in prognostic analysis.
Conclusions
This study successfully developed and validated a prognostic signature (IRPS) based on comprehensive immune cell infiltration analysis, along with its integrated index (ICPI). IRPS/ICPI serves as an effective tool for predicting BLCA patient prognosis and guiding immunotherapy strategies, while also aiding in the identification of patient populations likely to benefit from immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Urology, Renmin Hospital of Wuhan University, wuhan, Hubei, China.
- College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.
ORCID-Profile: Tong-Zu Liu, Sheng Li
Zitieren
APA
Yan, X., Tang, X., Guo, L., He, Z., Liu, S., Wu, S., Li, Z., Liu, T. Z., Zheng, H., Zhang, W., & Li, S. (2026). Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71737
Vancouver
Yan X, Tang X, Guo L, He Z, Liu S, Wu S, et al. Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71737
BibTeX
@article{Yan2026,
author = {Yan, Xin and Tang, Xiaoyu and Guo, Linfa and He, Ziqi and Liu, Shaoxi and Wu, Shaojie and Li, Zhilong and Liu, Tong-Zu and Zheng, Hang and Zhang, Weibing and Li, Sheng},
title = {Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cam4.71737}
}
EUVIMED